Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
Read the full story at BBC World ↗
ImpactNotable
Published3 d ago (Tue, 10 Nov 2026 18:43:04 GMT)
MoreLess
Impact score39/100
RatingProbability of 72%. Section Medicine with a probability of 99%.
RegionsGlobal
Retrievedvia rss
ClassifiedWed, 11 Nov 2026 00:02:58 GMT by classifier